Source - RNS
RNS Number : 6049K
MD Medical Group Investments PLC
23 September 2016





23 September 2016, Moscow - MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE:MDMG), a leading Russian private healthcare provider, today opened an interventional cardiology and cardiovascular surgery department at Lapino hospital as well as a new out-patient medical centre in Odintsovo, in the Moscow Region.

The interventional cardiology and cardiovascular surgery department will offer emergency (for patients with acute coronary syndrome, myocardial infarction, heartbeat arrhythmia, etc.) and routine (for patients with        chronic cardiac failure, coronary heart disease, etc.) care. It is expected that the department will also carry out high-tech endovascular diagnostics and operative treatments.

The department is equipped with advanced equipment by leading international suppliers. It comprises a therapeutic unit and an operating unit which focus on minimally invasive surgery, as well as an intensive care unit. The department, with a total area of 435 sq m, will be able to complete up to 500 coronary angiography and up to 200 angioplasty procedures per year.

Given the extremely important social impact of medical facilities providing emergency and high-tech care for patients with heart disease, Lapino's management decided to enrol in the complimentary care programme backed by state guarantees for Russian citizens requiring cardiovascular surgery in 2017.

The new out-patient medical centre in Odintsovo with a total area of 140 sq m offers OBGYN, ultrasound screening, urology, otolaryngology, neurology and surgery. The clinic is conveniently located in the town centre. The medical centre effectively serves as a branch of Lapino hospital and is located only 10 km from the hospital - the Group's largest medical facility. It is expected that the new clinic will further contribute to the ramp-up of Lapino. The medical centre will be able to carry out up to 30,000 specialist treatments per year.


Mark Kurtser, CEO of MDMG, said: 

"We have now expanded further our presence in the Moscow region with the opening a new high-tech   interventional cardiology and cardiovascular surgery department and a new clinic. This is yet another important and sustainable step forward in our development in the Moscow region, as we consolidate still further our leading position in Russia.

"The new world-class department at Lapino thanks to the hospital's location will be able to provide emergency and routine care to residents of Moscow and the Moscow Region. The department is well-equipped and its team consists of some of the best surgeons in the market, with long-standing experience in successfully carrying out complex surgery procedures.

"The new medical centre located near Lapino in Odintsovo will offer not only our signature services for women, but also additional healthcare services. Patients will also be able to receive additional treatment and a wider range of services in Lapino itself. In this way, we expect that the new clinic will further support the improving performance of Lapino."


For further information please contact:



Elena Romanova

MD Medical Group Investments Plc

Tel: +7 495 331 4120
[email protected]


Tom Blackwell: +7 919 102 9064

Sergii Pershyn: +1 929 855 8188

[email protected]


About MD Medical Group


MD Medical Group operates in the highly attractive Russian private healthcare service market and has a leading position in high-quality women's health and paediatrics. The company manages 31 modern healthcare facilities, including 4 hospitals and 27 outpatient clinics in Moscow and Moscow region, St. Petersburg, Ufa, Perm, Samara and Samara region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, and Barnaul.


The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.


Forward-Looking Statements:

This press release contains forward looking statements, which are based on the Company's current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company's ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.

No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.

This information is provided by RNS
The company news service from the London Stock Exchange